FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to compounds of the formula (I) where R1 and R2 mean cycloalkyl group, aryl group, heterocyclic group; R3 and R4 mean hydrogen atom or alkyl group; R5 means hydrogen atom, alkyl; R6 means hydroxy-group, alkylthio-group or amine residue; X and Y mean oxygen atom; Z means a single bond between indicated nitrogen atom and benzene ring or alkylene group; G means a direct bond, alkyl, alkylene; dotted line means a single or double bond; D means carbon atom and E means the group =N-O. These compounds show inhibitory activity against bile acids and therefore they can be used for preparing drug for inhibition of bile acid carrier in jejunum and for treatment and prophylaxis of hyperchlolesterolemia. EFFECT: valuable medicinal properties of compounds. (I) , 46 cl, 8 tbl, 141 ex
Title |
Year |
Author |
Number |
METHOD AND COMPOSITION FOR TREATING AND PREVENTING HYPERURICEMIA |
1998 |
- Fudzivara Tosikhiko
- Ivasaki Koiti
- Khorikosi Khiroesi
|
RU2190425C2 |
PREPARATION FOR TREATING AND PREVENTING CACHEXIA |
1998 |
- Kurakata Siniti
- Khanai Masakharu
- Kanai Saori
- Kimura Tomio
|
RU2190399C2 |
DERIVATIVES OF PHENYLALKYLCARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1997 |
- Janagisava Khiroaki
- Takamura Makoto
- Fudzita Takasi
- Fudzivara Tosikhiko
|
RU2169141C2 |
ACYLATED HETEROALICYCLIC DERIVATIVES, MEDICINAL AGENT SHOWING SELECTIVE ANTAGONISTIC ACTIVITY AGAINST NK-RECEPTORS, METHOD OF PROPHYLAXIS OR TREATMENT OF PATIENTS |
1998 |
- Nisi Takakhide
- Jamaguti Takesi
|
RU2174122C1 |
HETEROCYCLIC COMPOUNDS AND COMPOSITION ON SAID SHOWING ANTAGONISTIC EFFECT WITH RESPECT TO TACHYKININ RECEPTORS |
1996 |
- Takakhide Nisi
- Koki Isibasi
- Katsujosi Nakadzima
- Tetsuja Fukazava
- Khitosi Kurata
- Takesi Jamaguti
- Kazukhiro Ito
|
RU2135494C1 |
DERIVATIVES OF PYRROLE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT |
2000 |
- Kimura Tomio
- Aoki Kazumasa
- Nakao Akira
- Usijama Sigeru
- Simozato Takaiti
- Okhkava Nobujuki
|
RU2198170C2 |
DERIVATIVES OF DIARYLALKANES CONTAINING ALICYCLIC GROUP AND ELICITING ANTAGONISM WITH RESPECT TO SEROTONIN-2-RECEPTORS AND/OR INHIBITORY ACTIVITY WITH RESPECT TO SQUALENE SYNTHASE, COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF CARDIOVASCULAR DISEASES |
1997 |
- Koiti Fudzimoto
- Naoki Tanaka
- Fumitosi Asaj
- Taketosi Ogava
- Tejitiro Koga
- Tatsuo Tanimoto
- Esio Tsudzita
- Khirojuki Kojke
|
RU2139277C1 |
SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUND, METHOD OF PHARMACOLOGICAL EFFECT, METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY, INHIBITION OF LIPID PEROXIDES PRODUCTION OR BLOOD SUGAR LEVEL DECREASE |
1998 |
- Fudzita Takasi
- Vada Kunio
- Fudzivara Tosikhiko
|
RU2196141C2 |
SULFONAMIDE DERIVATIVE, MEDICINAL AGENT, METHODS FOR TREATMENT |
1999 |
- Kimura Tomio
- Mijazaki Soudziro
- Ueda Kejdzi
- Tanzava Kazukhiko
- Usijama Sigeru
- Takasaki Vataru
|
RU2217418C2 |
3-CYANOANDROSTA-3,5-DIENE-17BETA-CARBOXYLIC ACID AS INTERMEDIATE PRODUCT, AND METHOD OF PREPARING COMPOUNDS |
1993 |
- Koiti Kodzima
- Khitosi Kurata
- Koki Isibasi
- Takakazu Khamada
- Khirojossi Khorikosi
|
RU2114861C1 |